Bell-Kenz Pharma Denies Allegations of Multi-Level Marketing Scheme
Bell-Kenz Pharma, a pharmaceutical company, has recently faced allegations of using a multi-level marketing scheme to sell its medicines. However, the company’s Chief Executive Officer, Dr. Luis Go, firmly denied these allegations during a hearing held by the Senate Committee on Health, led by Senator Bong Go.
Accusations of Bribing Doctors
Several senators, including JV Ejercito, Jinggoy Estrada, and Raffy Tulfo, have accused Bell-Kenz Pharma of bribing doctors to prescribe their medicines in exchange for commissions. Ejercito highlighted that many pharmaceutical firms have been influencing doctors to prescribe their branded drugs, offering cash, cars, and all-expense-paid trips as incentives. He expressed concern that such practices undermine efforts to make healthcare more affordable.
Complex Multi-Level Organization
Ejercito specifically mentioned that Bell-Kenz Pharma operates a complex multi-level organization, involving a network of over 50 doctors spanning from northern Luzon to Mindanao. These allegations have raised serious questions about the company’s business practices and ethical standards.
It is important to note that these allegations have not been substantiated, and Bell-Kenz Pharma has vehemently denied engaging in unfair business competition or illegal activities.
Bell-Kenz Pharma’s Commitment to Affordable Healthcare
During the Senate hearing, Dr. Luis Go emphasized Bell-Kenz Pharma’s dedication to providing affordable public healthcare. He stated that the company’s ethos revolves around patient-centered care and a commitment to transparency. Dr. Go assured the senators that Bell-Kenz Pharma adheres to the rules and regulations set by the Food and Drug Administration, the Securities and Exchange Commission, the Philippine Medical Association, and other relevant governing bodies.
Dr. Go also highlighted the cost-saving benefits of Bell-Kenz Pharma’s medicines for hypertension and diabetes. According to him, patients can save an estimated amount of P128 daily or P27,000 to P55,000 yearly, depending on the brand. These savings can significantly alleviate the financial burden on patients.
Impact on Universal Health Care Program
Senator Ejercito, the author of the Universal Health Care (UHC) program, expressed concern that the alleged practice of bribing doctors with cash gifts and trips abroad in exchange for prescriptions adversely affects the program’s objectives. The UHC program aims to lower the out-of-pocket medicine expenses of every Filipino, which declined to 44.7 percent in 2022.
Senator Bong Go echoed these concerns and emphasized the importance of upholding ethical standards in the medical profession. He called for the protection of patients’ rights and the integrity of the entire public health system. While acknowledging the professionalism of most doctors, Senator Go warned about the detrimental effects of a few who might abuse their position, potentially leading to public mistrust.
It is crucial to thoroughly investigate these allegations and ensure that the medical profession maintains its integrity and the trust of the public.
Conclusion
The allegations against Bell-Kenz Pharma regarding a multi-level marketing scheme and bribing doctors have raised serious concerns about the company’s business practices and their impact on healthcare affordability. However, the company has firmly denied these allegations and emphasized its commitment to providing affordable public healthcare.
The Senate inquiry into these allegations serves as an opportunity to shed light on the matter and ensure that ethical standards are upheld within the medical profession. It is crucial to protect patients’ rights and maintain the integrity of the entire public health system.
While the majority of doctors are dedicated professionals, it is important to address any instances of abuse or unethical behavior that may erode public trust. By doing so, we can work towards a healthcare system that is transparent, affordable, and trustworthy for all Filipinos.
Source: The Manila Times